1. Khaledi S, Ahmadi S. Amyloid Beta and Tau: from Physiology to Pathology in Alzheimer's disease. Shefaye Khatam. 2016; 4(4): 67-88. [DOI:10.18869/acadpub.shefa.4.4.67]

2. Sayad A, Noruzinia M, Zamani M, Harirchian MH, Kazemnezhad A. LRP C766T polymorphism in Iranian patients with late-onset Alzheimer's Disease. Pathobiology Research. 2011; 14(3): 61-8.

3. Alzheimer's disease facts and figures. Alzheimer's & Dementia. 2020; 16(3): 391-460. [DOI:10.1002/alz.12068]

4. Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO molecular medicine. 2016; 8(6): 595-608. [DOI:10.15252/emmm.201606210]

5. Zheng H, Koo EH. The amyloid precursor protein: beyond amyloid. Molecular neurodegeneration. 2006; 1(1): 1-12. [DOI:10.1186/1750-1326-1-5]

6. Cirrito JR, Kang J-E, Lee J, Stewart FR, Verges DK, Silverio LM, et al. Endocytosis is required for synaptic activity-dependent release of amyloid-β in vivo. Neuron. 2008; 58(1): 42-51. [DOI:10.1016/j.neuron.2008.02.003]

7. LaFerla FM, Green KN, Oddo S. Intracellular amyloid-β in Alzheimer's disease. Nature Reviews Neuroscience. 2007; 8(7): 499-509. [DOI:10.1038/nrn2168]

8. Mockett BG, Richter M, Abraham WC, Müller UC. Therapeutic potential of secreted amyloid precursor protein APPsα. Frontiers in molecular neuroscience. 2017; 10: 30. [DOI:10.3389/fnmol.2017.00030]

9. Uddin MS, Kabir MT. Emerging signal regulating potential of genistein against Alzheimer's disease: a promising molecule of interest. Frontiers in Cell and Developmental Biology. 2019; 7: 197. [DOI:10.3389/fcell.2019.00197]

10. O'brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer's disease. Annual review of neuroscience. 2011; 34: 185. [DOI:10.1146/annurev-neuro-061010-113613]

11. Bi X. Alzheimer disease: update on basic mechanisms. Journal of Osteopathic Medicine. 2010; 110(s98): 3-9.

12. Peric A, Annaert W. Early etiology of Alzheimer's disease: tipping the balance toward autophagy or endosomal dysfunction? Acta neuropathologica. 2015; 129(3): 363-81. [DOI:10.1007/s00401-014-1379-7]

13. Derisbourg M, Leghay C, Chiappetta G, Fernandez-Gomez F-J, Laurent C, Demeyer D, et al. Role of the Tau N-terminal region in microtubule stabilization revealed by newendogenous truncated forms. Scientific reports. 2015; 5(1): 1-10. [DOI:10.1038/srep09659]

14. Dorostkar MM, Zou C, Blazquez-Llorca L, Herms J. Analyzing dendritic spine pathology in Alzheimer's disease: problems and opportunities. Acta neuropathologica. 2015; 130(1): 1-19. [DOI:10.1007/s00401-015-1449-5]

15. Busche MA, Hyman BT. Synergy between amyloid-β and tau in Alzheimer's disease. Nature neuroscience. 2020; 23(10): 1183-93. [DOI:10.1038/s41593-020-0687-6]

16. Yamazaki Y, Zhao N, Caulfield TR, Liu C-C, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nature Reviews Neurology. 2019; 15(9): 501-18. [DOI:10.1038/s41582-019-0228-7]

17. Pasand Mojdeh H, Alipour F, Borhani Haghighi M. Alzheimer's disease: Background, current and future aspects. The Neuroscience Journal of Shefaye Khatam. 2016; 4(3): 70-80. [DOI:10.18869/acadpub.shefa.4.3.70]

18. Martorell AJ, Paulson AL, Suk H-J, Abdurrob F, Drummond GT, Guan W, et al. Multi-sensory gamma stimulation ameliorates Alzheimer's-associated pathology and improves cognition. Cell. 2019; 177(2): 256-71. e22. [DOI:10.1016/j.cell.2019.02.014]

19. El Haj M, Postal V, Allain P. Music enhances autobiographical memory in mild Alzheimer's disease. Educational Gerontology. 2012; 38(1): 30-41. [DOI:10.1080/03601277.2010.515897]

20. Foster NA, Valentine ER. The effect of auditory stimulation on autobiographical recall in dementia. Experimental aging research. 2001; 27(3): 215-28. [DOI:10.1080/036107301300208664]

21. Irish M, Cunningham CJ, Walsh JB, Coakley D, Lawlor BA, Robertson IH, et al. Investigating the enhancing effect of music on autobiographical memory in mild Alzheimer's disease. Dementia and geriatric cognitive disorders. 2006; 22(1): 108-20. [DOI:10.1159/000093487]

22. Liu X, Zuo H, Wang D, Peng R, Song T, Wang S, et al. Improvement of spatial memory disorder and hippocampal damage by exposure to electromagnetic fields in an Alzheimer's disease rat model. PloS one. 2015; 10(5): e0126963. [DOI:10.1371/journal.pone.0126963]

23. Arendash GW. Review of the evidence that transcranial electromagnetic treatment will be a safe and effective therapeutic against Alzheimer's disease. Journal of Alzheimer's Disease. 2016; 53(3): 753-71. [DOI:10.3233/JAD-160165]

24. Tekieh E, Kazemi M, Tavakoli H, Saberi M, Ghanaati H, Hajinasrollah M, et al. The Effect of Extremely Low Frequency Electromagnetic Fields on Visual Learning, Memory and Anatomical Structures of the Brain in Male Rhesus Monkeys. ISMJ. 2018; 21(1): 40-53. [DOI:10.29252/ismj.21.1.40]

25. D'Arrigo JS. Nanotherapy for Alzheimer's disease and vascular dementia: Targeting senile endothelium. Advances in Colloid and Interface Science. 2018; 251: 44-54. [DOI:10.1016/j.cis.2017.12.002]

26. Gu X, Chen H, Gao X. Nanotherapeutic strategies for the treatment of Alzheimer's disease. Therapeutic Delivery. 2015; 6(2): 177-95. [DOI:10.4155/tde.14.97]

27. Liu G, Garrett MR, Men P, Zhu X, Perry G, Smith MA. Nanoparticle and other metal chelation therapeutics in Alzheimer disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2005; 1741(3): 246-52. [DOI:10.1016/j.bbadis.2005.06.006]